Major players in the pharmaceutical excipients market are, Archer Daniels Midland Co. , Associated British Foods, Dow Chemical Company, Evonik, Croda International Plc, Ashland, BASF SE, The Lubrizol Corporation, and Roquette Frères.
New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical Excipients Global Market Report 2021: COVID-19 Growth And Change To 2030" - https://www.reportlinker.com/p06151671/?utm_source=GNW
The global pharmaceutical excipients market is expected to grow from $6.21 billion in 2020 to $6.58 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $8.68 billion in 2025 at a CAGR of 7%.
The pharmaceutical excipients market consists of sales of pharmaceutical excipients and related services.The excipient is a substance, not an active pharmaceutical ingredient (API) that has been evaluated for safety, and intentionally added in a drug delivery system.
Excipient’s major roles are to protect, support, enhance stability, bioavailability, patient acceptability, and assist in the effectiveness. The market consists of revenue generated by the company’s manufacturing the pharmaceutical excipients by the sales of these excipients
The pharmaceutical excipients market covered in this report is segmented by functionality into fillers and diluents, suspending and viscosity agents, coating agents, binders, flavouring agents and sweeteners, disintegrants, colorants, lubricants and glidants, others, and by type of formulation into oral formulation, topical formulation, parental formulation.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market.According to the Pharmaceutical Journal, there are certain complications in children with the use of pharmaceutical drugs with excipients.
For instance, the colorants used in medicine as a coloring agent may lead to sensitivity reactions and hyperactive behaviour in children.Ethanol is another solvent that is widely used in an oral liquid formulation, the use of ethanol mixed medicine for children may have a risk of acute intoxication when overdose, and it may lead chronic toxicity with long term use.
Concerns related to safety and quality are expected to limit the growth of the pharmaceutical excipients market.
In December 2018, Roquette, a global manufacturer of plant-based excipients, acquired the majority stake in Crest Cellulose for an undisclosed amount.This acquisition will increase Roquette’s footprint in India and expand its portfolio.
Crest Cellulose is an India-based excipient manufacturer.
The global surge in the sale of generic drugs contributed to the growth of the pharmaceutical excipients market.Generic drugs are alternatives to the marketed brand name drug in the same dosage form, safety, strength, and route of administration and quality.
According to India Brand Equity Foundation (IBEF), India is the largest provider of generic medicines, the country’s generic drugs account for 20% of the global generic drug exports.Indian pharmaceutical companies received 300 generic drug approvals in the USA.
The surge in the demand for generic drugs drives the pharmaceutical excipients market.
The increase in research and development in the pharmaceutical formulation to enhance the production process and product quality by using multi-functional excipients is a trend shaping the market.Excipients play a significant role in helping pharmaceutical manufacturers better support patients by increasing compliance and treatment effectiveness.
For instance, Evonik’s newly launched EUDRAGIT FS 100 is a solid version of the existing EUDRAGIT FS 30 D. This new multi-functional version allows pharmaceutical companies to use the polymer in many new applications, such as hot-melt extrusion, solvent spray-drying, and solvent coating, which was impossible to achieve in past decades where only the aqueous version was available.
The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Read the full report: https://www.reportlinker.com/p06151671/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001